Literature DB >> 29407465

Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation.

Ivayla Apostolova1, Catharina Lange2, Anja Mäurer3, Per Suppa4, Lothar Spies4, Michel J Grothe5, Till Nierhaus6, Jochen B Fiebach7, Elisabeth Steinhagen-Thiessen8, R Buchert9.   

Abstract

Structural deterioration and volume loss of the hippocampal formation is observed in many diseases associated with memory decline. Paradoxically, glucose metabolism of the hippocampal formation can be increased at the same time. This might be a consequence of compensatory (beneficial) or maladaptive (detrimental) mechanisms. Aim of this study was to differentiate between compensation and maladaptation by analyzing the association between glucose metabolism in the hippocampal formation measured by positron emission tomography with the glucose analogue 18F-fluorodeoxyglucose and cognitive performance as characterized by the extended Consortium to Establish a Registry for Alzheimer's Disease test battery in a sample of 87 patients (81.8 ± 5.4 years) with mild cognitive impairment or mild dementia and varying etiological diagnoses. Glucose metabolism in the hippocampal formation was negatively correlated with the performance in several cognitive subdomains, most pronounced for verbal semantic fluency, independent of overall neuronal dysfunction, presence of clinical Alzheimer's disease, and overall cognitive performance. This finding provides evidence that increased glucose metabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation rather than a beneficial compensatory reaction. Excess glucose metabolism in the hippocampal formation might be a useful therapeutic target in these patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Dementia; Geriatric inpatients; Hippocampal formation; Hypermetabolism; Positron emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29407465     DOI: 10.1016/j.neurobiolaging.2018.01.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

1.  Brain effect of bariatric surgery in people with obesity.

Authors:  Angela Dardano; Gayane Aghakhanyan; Carlo Moretto; Annamaria Ciccarone; Rosario Bellini; Veronica Sancho Bornez; Giovanni Ceccarini; Ferruccio Santini; Duccio Volterrani; Stefano Del Prato; Giuseppe Daniele
Journal:  Int J Obes (Lond)       Date:  2022-06-21       Impact factor: 5.551

Review 2.  Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?

Authors:  Sara Merlo; Simona Federica Spampinato; Maria Angela Sortino
Journal:  CNS Neurosci Ther       Date:  2018-08-12       Impact factor: 5.243

3.  EEG-fMRI Signal Coupling Is Modulated in Subjects With Mild Cognitive Impairment and Amyloid Deposition.

Authors:  Lars Michels; Florian Riese; Rafael Meyer; Andrea M Kälin; Sandra E Leh; Paul G Unschuld; Roger Luechinger; Christoph Hock; Ruth O'Gorman; Spyros Kollias; Anton Gietl
Journal:  Front Aging Neurosci       Date:  2021-04-23       Impact factor: 5.750

4.  FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.

Authors:  Anna Rubinski; Nicolai Franzmeier; Julia Neitzel; Michael Ewers
Journal:  Alzheimers Res Ther       Date:  2020-10-19       Impact factor: 6.982

5.  Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.

Authors:  Yifan Chen; Junkai Wang; Chunlei Cui; Yusheng Su; Donglai Jing; LiYong Wu; Peipeng Liang; Zhigang Liang
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

6.  Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer's disease.

Authors:  Hongyoon Choi; Yoori Choi; Eun Ji Lee; Hyun Kim; Youngsun Lee; Seokjun Kwon; Do Won Hwang; Dong Soo Lee
Journal:  J Neuroinflammation       Date:  2021-08-31       Impact factor: 8.322

7.  Residual reserve index modifies the effect of amyloid pathology on fluorodeoxyglucose metabolism: Implications for efficiency and capacity in cognitive reserve.

Authors:  Cathryn McKenzie; Romola S Bucks; Michael Weinborn; Pierrick Bourgeat; Olivier Salvado; Brandon E Gavett
Journal:  Front Aging Neurosci       Date:  2022-08-12       Impact factor: 5.702

8.  Predicting cognitive decline in Parkinson's disease using FDG-PET-based supervised learning.

Authors:  Samuel Booth; Kye Won Park; Chong Sik Lee; Ji Hyun Ko
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.